Wells Fargo & Company »

Cartesian Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $81k 7.9k 10.21
2025-06-30 $61k 5.8k 10.39
2025-03-31 $65k 5.0k 13.18
2024-12-31 $87k 4.8k 17.91
2024-09-30 $37k 2.3k 16.11
2024-06-30 $64k 2.4k 27.01